Novartis | NVS - Beneficio Operativo

Precio De Mercado
146.03
Cambio Diario
-2.13 -1.44%
Mensual
-11.34%
Anual
30.22%
Q1 Expectativa
142.44




Beneficio Operativo Cambio Fecha
AbbVie USD 5.81B 1.23B 2025-12
Amgen USD 3.96B 464M 2025-12
AstraZeneca USD 2.97B 4.48B 2025-12
Bausch Health Companies USD 719M 2M 2025-12
Biogen USD 659.6M 192.2M 2025-09
Bristol-Myers Squibb USD 4.2B 562M 2025-12
Canopy Growth CAD -12.66M 1.64M 2025-12
Corcept Therapeutics USD 4.49M 5.73M 2025-12
Drreddys Laboratories INR 14.33B 2.51B 2025-12
Eli Lilly USD 8.99B 599.9M 2025-12
Gilead Sciences USD 2.96B 551M 2025-12
GlaxoSmithKline GBP 1.44B 1.35B 2025-12
Glaxosmithkline GBP 2.3B 1.46B 2025-12
J&J USD 5.59B 1.81B 2025-12
Merck USD 6.24B 318M 2025-12
Novartis USD 4.06B 437M 2025-12
Novartis USD 4.06B 521M 2025-12
Pacira USD 3.19M 9.96M 2025-12
Perrigo USD 84.4M 9M 2025-12
Pfizer USD 4.65B 3.99B 2025-12
Phibro Animal Health USD 54.99M 2.36M 2025-12
Prestige Brands USD 82.49M 2.82M 2025-12
Roche Holding CHF 9.56B 3.8B 2025-12
Sanofi EUR 1.7B 2.17B 2025-12
Sanofi EUR 1.5B 2.29B 2025-12
Supernus Pharmaceuticals USD 13.82M 74.01M 2025-12
Zoetis USD 835M 101M 2025-12